Microbiological evaluation of commercial probiotic products available in Italy

Journal of Chemotherapy

Volumn 16, Issue 5, 2004, Pages 463-467

  Drago, L ^a   De Vecchi, E ^a   Nicola, L ^a   Colombo, A ^a   Gismondo, M R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Lactobacilli; Probiotics; Product stability

Indexed keywords

BILE SALT; DICOFLOR; ENTEROLACTIS; NEOLACTOFLORENE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; YOVIS;

ACIDITY; ARTICLE; BACTERIAL GROWTH; BIFILACT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG SCREENING; DRUG STABILITY; DRUG STORAGE; GROWTH INHIBITION; ITALY; LACTOBACILLUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PH; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 8544246411     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.5.436     Document Type: Article

References (14)

1. Fuller R. Probiotics in man and animals. J Appl Bact 1989; 66: 365-78.
2. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998; 39: 237-238.
3. Schrezenmeier J, de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001; 73 (Suppl): 361S-364S.
4. Weese SJ. Microbiologic evaluation of commercial probiotics. JAMA 2002; 220: 794-797.
5. Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr 2001; 73: 1147S-1151S.
6. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9: 175-91.
7. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000; 95(suppl): S11-S13.
8. Gorbach SL. Probiotics and gastrointestinal health. J Gastroenterol 2000; 95(suppl): S1-S4.
9. Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 2003; 81: 1-10.
10. Hamilton-Miller JMT, Shah S. Deficiencies in microbiological quality and labelling of probiotic supplements. Int J Food Microbiol 2002; 72: 175-176.
11. Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003; 82: 59-70.
12. Sanders ME, Veld JH. Bringing a probiotic-containing functional food to the market: microbiological, product regulatory and labelling issues. Antonie van Leeuwenhoek 1999; 76: 293-315.
13. Sanders ME. Probiotics: consideration for human health. Nutr Rev 2003; 61: 91-99.
14. Przyrembel H. Consideration of possible legislation within existing regulatory frameworks. Am J Clin Nutr 2001; 73: 471s-475s.